Finally, we discuss the recent applications including the diseases related to insulin resistance (obesity, cardiovascular disease, Alzheimer’s disease, and cancer) and the potential treatment of those based on insulin resistance mechanisms. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.